Find stats on top websites
The healthcare technology industry is experiencing rapid growth, driven by increasing adoption of AI, big data, and automation to improve efficiency, reduce costs, and enhance patient care. Digital transformation in hospitals, especially in high-stakes environments like ORs, is a key trend. Focus on interoperability, data security, and value-based care models continues to shape innovation and investment.
Total Assets Under Management (AUM)
Hospital IT Spending in United States
~Approximately 140 billion USD
(10-15% CAGR)
- Digital transformation initiatives.
- EHR optimization and integration.
- Cybersecurity and data analytics investments.
140 billion USD
Generative AI can automate and streamline clinical documentation, reducing the administrative burden on healthcare professionals and improving data quality.
Digital twins of patients, organs, or even entire hospital systems can enable predictive modeling for personalized treatment plans, resource optimization, and operational forecasting.
Processing AI algorithms directly on medical devices at the 'edge' of the network improves real-time performance, reduces latency, and enhances data security by minimizing cloud transfers.
The 21st Century Cures Act, specifically the information blocking rule enforced in 2021, mandates that healthcare providers, health IT developers, and health information exchanges do not knowingly and unreasonably interfere with the access, exchange, or use of electronic health information (EHI).
This policy significantly boosts interoperability requirements, pushing Apella to ensure seamless and secure integration with various EHR systems for data exchange and real-time insights.
The HIPAA Security Rule, established in 1996 and continuously enforced, sets national standards for protecting electronic protected health information (ePHI) that is created, received, used, or maintained by a covered entity.
HIPAA's stringent security requirements heavily influence Apella's data privacy, encryption, and access control measures, particularly given its use of video and sensitive OR data.
While not yet fully finalized as a regulation, the FDA's Digital Health Software Precertification Program (Pre-Cert), initiated in 2017, aims to streamline the regulatory review process for software as a medical device (SaMD) from companies demonstrating a commitment to quality and organizational excellence.
Although still evolving, this program could potentially accelerate the market entry of future advanced AI-driven features from Apella if its platform were to be classified as SaMD and the company qualifies for precertification.
Sign up now and unleash the power of AI for your business growth